Orchestra BioMed Appoints New Chief Medical Officer
Ticker: OBIO · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1814114
| Field | Detail |
|---|---|
| Company | Orchestra Biomed Holdings, Inc. (OBIO) |
| Form Type | 8-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, personnel
TL;DR
Orchestra BioMed just hired a new CMO from J&J. Big move for their pipeline.
AI Summary
Orchestra BioMed Holdings, Inc. announced on February 19, 2025, the appointment of Dr. Jonathan L. R. Roth as Chief Medical Officer. Dr. Roth, previously a Senior Medical Director at Johnson & Johnson, brings extensive experience in clinical development and medical affairs. This appointment is part of the company's ongoing efforts to advance its pipeline of medical devices.
Why It Matters
The appointment of a new Chief Medical Officer with significant industry experience could signal a strategic shift or acceleration in the company's clinical development programs, potentially impacting future product approvals and market entry.
Risk Assessment
Risk Level: medium — The appointment of a key executive is a significant event, but the filing does not contain financial information or details about strategic changes that would indicate a higher risk level.
Key Players & Entities
- Orchestra BioMed Holdings, Inc. (company) — Registrant
- Dr. Jonathan L. R. Roth (person) — Appointed Chief Medical Officer
- Johnson & Johnson (company) — Previous employer of Dr. Roth
- February 19, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 150 Union Square Drive (address) — Principal executive offices
- New Hope, Pennsylvania (location) — City and State of principal executive offices
FAQ
What is the effective date of Dr. Jonathan L. R. Roth's appointment as Chief Medical Officer?
The earliest event reported is February 19, 2025, which is the effective date of the appointment.
What was Dr. Roth's previous role before joining Orchestra BioMed Holdings, Inc.?
Dr. Roth was previously a Senior Medical Director at Johnson & Johnson.
In which state is Orchestra BioMed Holdings, Inc. incorporated?
Orchestra BioMed Holdings, Inc. is incorporated in Delaware.
What is the principal executive office address for Orchestra BioMed Holdings, Inc.?
The principal executive offices are located at 150 Union Square Drive, New Hope, Pennsylvania 18938.
What is the SIC code for Orchestra BioMed Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 by Dr. Jonathan L. R. Roth regarding Orchestra BioMed Holdings, Inc. (OBIO).